One of the top reasons clinical trial professionals move from job to job in today’s high-turnover market is a feeling of stagnation in their current role, according to a new […]
Decentralized clinical trials (DCTs) offer opportunities to optimize efficiencies in clinical trials, a number of U.S. Food and Drug Administration (FDA) officials, including Dr. Isaac R. Rodriguez-Chavez, have said at […]
The U.S. Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) just laid down the gauntlet in a document promising an active 2020 chock full of guidances addressing […]
The problem of diversity in clinical trials won’t significantly improve until industry adapts more creative ways to “bring research to the community,” rather than expecting potential patients to jump through […]
Efforts by drug developers during the last decade to improve recruitment and retention of patients for clinical trials appear to be paying off, as enrollment timelines are now equal to […]